Trial intelligence / Profile preview

Diuretics vs Amlodipine in Hypertension with Sleep Apnea

NCT01896661Phase 3Completed

Sponsor
Hospital de Clínicas de Porto Alegre
Start
Dec 2014
Primary completion
Dec 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of chlorthalidone and amiloride in hypertension (HTN) and obstructive sleep apnea (OSA) (2 arms), sponsored by Hospital de Clínicas de Porto Alegre. Primary endpoints: Apnea-Hypopnea Index at 8 weeks and Blood Pressure at 8 weeks. Started Dec 2014; status: completed.

02

Drugs

chlorthalidoneamiloride
03

Conditions

hypertension (HTN)obstructive sleep apnea (OSA)

Beyond the preview

Go deeper on NCT01896661.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01896661.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call